+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

US Obesity Market and Competitive Landscape - 2021

  • ID: 5236047
  • Report
  • January 2021
  • Region: United States
  • Fore Pharma
1 of 3
The latest research US Obesity Market and Competitive Landscape Highlights - 2021, provides comprehensive insights into Obesity pipeline products, Obesity epidemiology, Obesity market valuations and forecast, Obesity drugs sales and competitive landscape in the US.

The research is classified into seven sections - Obesity treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:
  • Obesity pipeline: Find out the products in clinical trials for the treatment of Obesity by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Obesity epidemiology: Find out the number of patients diagnosed (prevalence) with Obesity in the US
  • Obesity drugs: Identify key products marketed and prescribed for Obesity in the US, including trade name, molecule name, and company
  • Obesity drugs sales: Find out the sales revenues of Obesity drugs in the US
  • Obesity market valuations: Find out the market size for Obesity drugs in 2019 in the US. Find out how the market advanced from 2017 and forecast to 2026
  • Obesity drugs market share: Find out the market shares for key Obesity drugs in the US
Benefits of this Research:

The research helps executives to
  • Support monitoring and reporting national Obesity market analysis and sales trends
  • Track competitor drugs sales and market share in the US Obesity market
  • Track competitive developments in Obesity market and present key issues and learnings
  • Synthesize insights for Obesity market and products to drive business performance
  • Answer key business questions about the Obesity market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Obesity products
  • Supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 3
1) Obesity Treatments
2) Obesity Pipeline
3) US Obesity Epidemiology
4) Marketed Drugs for Obesity in US
5) US Obesity Market Size and Forecast
6) US Obesity Products Sales and Forecast
7) US Obesity Market Competitive Landscape
8) Methodology
9) Contact us

List of Tables
1. Obesity Phase 3 Clinical Trials, 2021
2. Obesity Phase 2 Clinical Trials, 2021
3. Obesity Phase 1 Clinical Trials, 2021
4. Obesity Epidemiology, US, 2017 – 2026
5. Marketed Drugs for Obesity, US, 2020
6. Obesity Market Size and Forecast ($), US, 2017 – 2026
7. Obesity Product Sales ($), US, 2017 – 2026

List of Figures
1. Obesity Epidemiology, US, 2017 – 2026
2. Obesity Market Size and Forecast ($), US, 2017 – 2026
3. Obesity Products Market Share (%), US, 2019
Note: Product cover images may vary from those shown
3 of 3
  • US
Note: Product cover images may vary from those shown
Adroll
adroll